Skip to content
DraconiticResearch
Search Sources API
186,546 studies31 sourcesUpdated 6 min ago
Peer-reviewedCC BYJAAD international

Deucravacitinib versus placebo in adults with moderate-to-severe hidradenitis suppurativa: A pilot study.

  1. 1Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  2. 2Harvard Medical School, Boston, Massachusetts.
  3. 3Department of Medicine, Santa Barbara Cottage Hospital, Santa Barbara, California.

Related

  1. Efferocytosis-Related Transcriptional Dysregulation in Hidradenitis Suppurativa Lesional Macrophages: A Multi-Cohort Single-Cell and Bulk Transcriptomic Study
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Male-predominant, perianal-prone hidradenitis suppurativa in China: A cohort study of 614 patients.
    Yanyu Du, Jingwen Zou, Renliang He +1
    JAAD internationalPeer-reviewedCC BYFull text1 citedGeneral medicineEurope PMC
  3. Real-world patient journey and unmet needs of people with hidradenitis suppurativa: Social media research in China.
    John R Ingram, Wen-Yu Wu, Wenbo Bu +4
    JAAD internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Geospatial Associations of Hidradenitis Suppurativa With Structurally Related Airborne Toxins
    Tara McCaffrey, Beita Badiei, Nina Rossa Haddad +8
    JAMA DermatologyPeer-reviewedLicence not statedFull textGeneral medicinePMC
  5. Emotional and social burden of hidradenitis suppurativa: a qualitative multi-centre narrative medicine project in Italy
    Nevena Skroza, Cristina Magnoni, Elisa Molinelli +12
    BMJ OpenPeer-reviewedLicence not statedGeneral medicineCrossref
BibTeX
@article{porter2026deucravacitinib,
  title = {{Deucravacitinib versus placebo in adults with moderate-to-severe hidradenitis suppurativa: A pilot study.}},
  author = {Martina L Porter and Maneli Doroudian Tehrani and Nazrin Ashina and Bruna G O Wafae and Thao-Mary Tran and Hoang Truong and William Sweet and Julia L Gao and Prerna Salian and Alexa B Kimball},
  journal = {JAAD international},
  year = {2026},
  month = sep,
  doi = {10.1016/j.jdin.2026.08.009},
  url = {https://europepmc.org/article/MED/42898106},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Deucravacitinib versus placebo in adults with moderate-to-severe hidradenitis suppurativa: A pilot study.
AU  - Martina L Porter
AU  - Maneli Doroudian Tehrani
AU  - Nazrin Ashina
AU  - Bruna G O Wafae
AU  - Thao-Mary Tran
AU  - Hoang Truong
AU  - William Sweet
AU  - Julia L Gao
AU  - Prerna Salian
AU  - Alexa B Kimball
PY  - 2026
DA  - 2026/09/03
JO  - JAAD international
DO  - 10.1016/j.jdin.2026.08.009
UR  - https://europepmc.org/article/MED/42898106
SN  - 2666-3287
ER  -